| Product Code: ETC7344517 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Carbapenem Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Carbapenem Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Carbapenem Market - Industry Life Cycle |
3.4 Greece Carbapenem Market - Porter's Five Forces |
3.5 Greece Carbapenem Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Greece Carbapenem Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Greece Carbapenem Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Greece Carbapenem Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Greece |
4.2.2 Growing awareness about the effectiveness of carbapenems in treating serious infections |
4.2.3 Rise in healthcare expenditure and investments in advanced healthcare infrastructure in Greece |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines for antibiotic use in healthcare settings |
4.3.2 Emergence of antibiotic resistance leading to decreased efficacy of carbapenems |
4.3.3 High cost associated with carbapenem treatment impacting affordability for patients and healthcare facilities |
5 Greece Carbapenem Market Trends |
6 Greece Carbapenem Market, By Types |
6.1 Greece Carbapenem Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Greece Carbapenem Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Greece Carbapenem Market Revenues & Volume, By Meropenem, 2021- 2031F |
6.1.4 Greece Carbapenem Market Revenues & Volume, By Imipenem, 2021- 2031F |
6.1.5 Greece Carbapenem Market Revenues & Volume, By Ertapenem, 2021- 2031F |
6.2 Greece Carbapenem Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Greece Carbapenem Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Greece Carbapenem Market Revenues & Volume, By Bloodstream Infections, 2021- 2031F |
6.2.4 Greece Carbapenem Market Revenues & Volume, By Intra-abdominal Infections, 2021- 2031F |
6.2.5 Greece Carbapenem Market Revenues & Volume, By Pneumonia, 2021- 2031F |
6.3 Greece Carbapenem Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Greece Carbapenem Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Greece Carbapenem Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
7 Greece Carbapenem Market Import-Export Trade Statistics |
7.1 Greece Carbapenem Market Export to Major Countries |
7.2 Greece Carbapenem Market Imports from Major Countries |
8 Greece Carbapenem Market Key Performance Indicators |
8.1 Number of reported cases of bacterial infections in Greece |
8.2 Rate of adoption of carbapenems in healthcare facilities |
8.3 Investment in research and development for new carbapenem formulations |
8.4 Compliance with antibiotic stewardship programs in healthcare settings |
8.5 Number of educational campaigns on antibiotic resistance and appropriate antibiotic use in Greece |
9 Greece Carbapenem Market - Opportunity Assessment |
9.1 Greece Carbapenem Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Greece Carbapenem Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Greece Carbapenem Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Greece Carbapenem Market - Competitive Landscape |
10.1 Greece Carbapenem Market Revenue Share, By Companies, 2024 |
10.2 Greece Carbapenem Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |